Cell Therapy Market Insights
The cell
therapy market size is
projected to reach USD 31.2 Billion by 2032, at a CAGR of 9.1% from 2023 to
2032. The Cell Therapy Market is a rapidly evolving sector within
biotechnology, focused on harnessing the therapeutic potential of living cells
to treat various diseases and conditions. This market encompasses a diverse
range of cell-based therapies, including stem cell therapies, CAR-T cell
therapies, and regenerative medicine. Key drivers of market growth include
advancements in cell manufacturing technologies, increasing investments in
research and development, and a growing prevalence of chronic diseases
worldwide. Despite regulatory challenges and manufacturing complexities, the
market continues to expand, driven by promising clinical outcomes and a rising
demand for personalized and targeted treatment options.
Cell Therapy Market Players
The global cell
therapy market companies that have
been included in MRFR's report are
Cognate,
ANTEROGEN.CO., LTD.,
NuVasive, Inc.,
GlaxoSmithKline plc,
Osiris, PHARMICELL,
Pluristem,
Genzyme Corporation,
CELLECTIS,
Advanced Tissue,
Novartis AG,
EUFETS GmbH,
Cynata, BioNTech IMFS,
JCR Pharmaceuticals Co., Ltd,
Grupo Praxis, and
MEDIPOST among others.
The Cell Therapy Market has experienced significant growth in
recent years, driven by the rising demand for innovative treatments in
regenerative medicine. Stem
Cell Therapy, a key
component of this market, involves the use of stem cells to treat or prevent
diseases or conditions by replacing damaged or diseased cells with healthy
ones. Stem cells possess the unique ability to differentiate into various cell
types, making them promising candidates for treating a wide range of medical
conditions, including cardiovascular diseases, neurological disorders, and
autoimmune conditions. The increasing prevalence of chronic diseases coupled
with advancements in stem cell research and technology has propelled the growth
of the Stem Cell Therapy segment within the Cell Therapy Mark
Market Segmentation
The global cell therapy market outlook is segmented based on cell
source, type, technology, application, end-user, and region. By type, the
market is divided between autologous and allogeneic.
By technology, the market is segmented into viral vector
technology, somatic cell technology, cell immortalization technology, genome
editing technology, cell plasticity technology, and three-dimensional
technology. The viral vector segment is sub-segmented into in-vivo gene
modification of cells and ex-vivo gene modification of cells.
By cell source, the market is segmented to include bone marrow,
umbilical cord blood-derived cells, adipose tissue, pluripotent stem cells
(iPSCs), and neural stem cells.
By application, the market is segmented into cardiovascular,
musculoskeletal, gastrointestinal, neurological, dermatology, oncology, wound
& injuries, ocular, and others.
By end-user, the market is categorized into regenerative medicine
centres, diagnostic centres, hospitals & clinics, research institutes and
others.
The regional segmentation of the market divides it into the
Americas, Europe, Asia Pacific, and the Middle East & Africa.
Regional Analysis
The Americas with their inclusion of North America lead the market
with the largest share due to the rising awareness regarding cell therapy in
the region and the presence of an advanced healthcare sector. High healthcare
expenditure, the presence of a large geriatric population and the growing
demand for effective regenerative medicine are some of the important factors driving market
growth. Europe accounts for the second largest regional segment due to the
comparable growth pattern to that of the Americas. Moreover, the region has
forward-thinking government policies which support research and development in
the advancement of the healthcare sector.
The Asia Pacific accounts for the fastest growing region in the
global market due to the presence of a massive patient pool and a rapidly
developing healthcare sector. rising disposable incomes and urbanization in the
region has increased the demand for advanced healthcare. Healthcare expenditure
in the region is growing steadily and is expected to augment the cell therapy
market in APAC.
For more information, Please Visit us @ Market
Research Future
